Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 293
Selected: 0
NCT IDTitle
NCT00400803Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer
NCT02661035Allo HSCT Using RIC for Hematological Diseases
NCT02227797MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
NCT03642626MT2017-45: CAR-T Cell Therapy for Heme Malignancies
NCT04466098Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
NCT00373152MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer
NCT04090606Tobacco Constituents and Biomarkers
NCT06544811American Indian Smokefree Native RCT
NCT02042924Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
NCT05973656Role of Acetaldehyde in the Development of Oral Cancer
NCT05338658Study of PAT in Patients With Solid Tumor Cancers
NCT00381888Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
NCT00258427Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
NCT01312818Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
NCT07541573GTB-5550 in Advanced Solid Tumors
NCT03125642Auto Stem Cell Transplant for Lymphoma Patients
NCT00618540Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
NCT00871689Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML
NCT06213298Effect of Kava on Anxiety and Stress in Cancer Survivors
NCT01056601Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy
NCT05735717MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
NCT03981705Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
NCT02074631Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation
NCT05634512Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.
NCT00428194Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
NCT04055844Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
NCT04514471Feasibility Study - Filter Ventilation
NCT02395822MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients
NCT01105650Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
NCT00610740CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer
NCT05114837Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL
NCT00888316Iron Overload in Patients Undergoing Donor Stem Cell Transplant
NCT00177047Autologous Transplant for Multiple Myeloma
NCT03050216QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
NCT00006451Bone Marrow Transplantation in Treating Patients With Leukemia
NCT05700630Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia
NCT01400672Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma
NCT03316456Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction
NCT04426669A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
NCT00274846Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia
NCT04284254MT2018-18: Sleeping Beauty Transposon-Engineered Plasmablasts for Hurler Syndrome Post Allo HSCT
NCT00869323Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders
NCT00005986Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia
NCT00258362Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
NCT02525029Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
NCT05363267NF-1, Nutraceutical Intervention
NCT05809557EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
NCT00000105Vaccination With Tetanus and KLH to Assess Immune Responses.
NCT01451502Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
NCT00703638Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors